Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate.

Peterzan MA, Hardy R, Chaturvedi N, Hughes AD.

Hypertension. 2012 Jun;59(6):1104-9. doi: 10.1161/HYPERTENSIONAHA.111.190637. Epub 2012 Apr 30.

2.

Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.

Musini VM, Nazer M, Bassett K, Wright JM.

Cochrane Database Syst Rev. 2014 May 29;(5):CD003824. doi: 10.1002/14651858.CD003824.pub2. Review.

PMID:
24869750
3.

Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium.

Ernst ME, Carter BL, Zheng S, Grimm RH Jr.

Am J Hypertens. 2010 Apr;23(4):440-6. doi: 10.1038/ajh.2010.1. Epub 2010 Jan 28.

PMID:
20111008
4.

Determining the relative antihypertensive potency and relative cardiovascular risk reduction associated with different thiazide and thiazide-type diuretics.

Basile JN, Bloch MJ.

J Clin Hypertens (Greenwich). 2013 Jun;15(6):359-61. doi: 10.1111/jch.12079. Epub 2013 Feb 27. No abstract available.

5.

Thiazide and thiazide-like diuretics: perspectives on individualization of drug and dose based on therapeutic index.

Weir MR, Agarwal R.

Hypertension. 2012 Jun;59(6):1089-90. doi: 10.1161/HYPERTENSIONAHA.112.192153. Epub 2012 Apr 30. No abstract available.

6.

Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring.

Pareek AK, Messerli FH, Chandurkar NB, Dharmadhikari SK, Godbole AV, Kshirsagar PP, Agarwal MA, Sharma KH, Mathur SL, Kumbla MM.

J Am Coll Cardiol. 2016 Feb 2;67(4):379-389. doi: 10.1016/j.jacc.2015.10.083.

7.

Potency of office blood pressure from hydrochlorothiazide and chlorthalidone fails to explain cardiovascular events.

Roush GC, Guddati AK, Holford TR.

Hypertension. 2012 Sep;60(3):e22; author reply e23. doi: 10.1161/HYPERTENSIONAHA.112.200139. Epub 2012 Jul 16. No abstract available.

8.

Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure.

Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJ, Phillips BB, Zimmerman MB, Bergus GR.

Hypertension. 2006 Mar;47(3):352-8. Epub 2006 Jan 23.

9.

Evaluation of the efficacy and safety of a hydrochlorothiazide to chlorthalidone medication change in veterans with hypertension.

Matthews KA, Brenner MJ, Brenner AC.

Clin Ther. 2013 Sep;35(9):1423-30. doi: 10.1016/j.clinthera.2013.07.430. Epub 2013 Aug 29.

PMID:
23993697
10.

Hydrochlorothiazide and bendroflumethiazide in low doses--a comparative trial.

[No authors listed]

Acta Pharmacol Toxicol (Copenh). 1984;54 Suppl 1:47-51.

PMID:
6369883
11.

Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension.

Cushman WC, Bakris GL, White WB, Weber MA, Sica D, Roberts A, Lloyd E, Kupfer S.

Hypertension. 2012 Aug;60(2):310-8. doi: 10.1161/HYPERTENSIONAHA.111.188284. Epub 2012 Jun 18.

12.

Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects.

Roush GC, Ernst ME, Kostis JB, Tandon S, Sica DA.

Hypertension. 2015 May;65(5):1041-6. doi: 10.1161/HYPERTENSIONAHA.114.05021. Epub 2015 Mar 2. Review.

13.

Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability.

Carter BL, Ernst ME, Cohen JD.

Hypertension. 2004 Jan;43(1):4-9. Epub 2003 Nov 24. Review.

14.
15.

Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response.

Shahin MH, Sá AC, Webb A, Gong Y, Langaee T, McDonough CW, Riva A, Beitleshees AL, Chapman AB, Gums JG, Turner ST, Boerwinkle E, Scherer SE, Sadee W, Cooper-DeHoff RM, Johnson JA.

Circ Cardiovasc Genet. 2017 Jan;10(1). pii: e001404. doi: 10.1161/CIRCGENETICS.116.001404.

16.

Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.

Bakris GL, Sica D, White WB, Cushman WC, Weber MA, Handley A, Song E, Kupfer S.

Am J Med. 2012 Dec;125(12):1229.e1-1229.e10. doi: 10.1016/j.amjmed.2012.05.023. Epub 2012 Aug 30.

PMID:
22939358
17.

Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension.

Chen JM, Heran BS, Wright JM.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007187. doi: 10.1002/14651858.CD007187.pub2. Review.

PMID:
19821398
18.

Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.

Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, Cohen J, Davis BR, Frost P, Smith W, Gonzalez N, Guthrie GP, Oberman A, Rutan G, Probstfield JL, Stamler J.

Arch Intern Med. 1998 Apr 13;158(7):741-51.

PMID:
9554680
19.
20.

Double-blind comparison of hydrochlorothiazide plus triameterene therapy versus chlorthalidone therapy in hypertension.

Clark EC, Podolsky S, Thompson EJ.

South Med J. 1979 Jul;72(7):798-802. No abstract available.

PMID:
377507

Supplemental Content

Support Center